Our mission is to develop disease-modifying therapies to stop or reverse the progression of neurodegenerative diseases to address the unmet medical need.

Herantis Pharma logo

Find us on LinkedIn

 

  • Highlight

    Notice to Convene Herantis Pharma Plc's Annual General Meeting of Shareholders April 24, 2024

  • Highlight

    Annual Report for 2024

  • Highlight

    View Full Year 2024 report webinar

Latest news and releases